Technological Innovation Drive the Growth of Next Generation Diabetes Therapy and Drug Delivery Market by 2023

Next generation diabetes treatment and drug delivery devices are used to check blood glucose levels and deliver insulin into the body. The next generation diabetes drug delivery system, such as oral and inhalable insulin, helps to introduce insulin into the patient's body without causing pain, and reduces the risk of skin irritation due to frequent use of the needle. Advances in insulin patches, continuous glucose monitoring (CGM) systems, and diabetes treatment systems such as artificial pancreas are frequently used to detect glucose levels and regulate insulin levels to manage changes in glucose levels.

The increased number of diabetic patients and the advantage of using advanced diabetes instruments such as artificial pancreas and insulin patch compared to conventional products is expected to boost next-generation diabetes treatment and growth of the drug delivery market. In addition, increasing disposable income among diabetic patients and technologically advancing next-generation diabetes products is expected to boost market growth.

An increase in medical expenses in developing countries such as India and China is expected to provide opportunities for market expansion. However, the lack of consciousness in developing countries, low product variability, and cost constraints are expected to hamper market growth. The global market was valued at $617 million in 2015 and is expected to garner $9,673 million by 2022, registering a CAGR of 41.1% during the forecast period 2016 - 2023.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/2098?utm_source=openpr_ss

Major Market Players:
• Abbott Laboratories
• Medtronic Inc.
• Sanofi
• Novo Nordisk
• MannKind Corporation
• Enteris BioPharma
• Dexcom

The CGM system is an established product and dominates the market due to the existence of a large patient base suffering from diabetes with the highest market share in 2015, and in the future from the viewpoint of revenue It is expected that the trend will continue. The advantage of these systems when compared to traditional diabetic products is the efficient and early detection of ease of use and changes in blood glucose levels expected to boost this segment's growth.

Key Findings of Next Generation Diabetes Therapy and Drug Delivery Market:

• The artificial pancreas segment is predicted to grow at the highest rate during the analysis period.
• The CGM system is the segment that produced the highest revenue and is expected to maintain its superiority in the future.
• North America dominates the worldwide next-generation diabetes treatment drug and drug delivery market and is expected to grow at a CAGR of 40%.
• India is the fastest growing in the Asia Pacific region, CAGR is 51.1%.
Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2098?utm_source=openpr_ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.